Kinnate Biopharma
Patents, Design & Utilities

Last updated:

List of all Kinnate Biopharma patents 15 in total

Status Patent
Grant
Utility: Inhibitors of cyclin-dependent kinases External link
Filling date: 7 Sep 2025 Issue date: 20 Sep 2022
Grant
Utility: Inhibitors of RAF kinases External link
Filling date: 7 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Inhibitors of cyclin-dependent kinases External link
Filling date: 7 Sep 2025 Issue date: 19 Jul 2022
Grant
Utility: Inhibitors of RAF kinases External link
Filling date: 7 Sep 2025 Issue date: 5 Jul 2022
Grant
Utility: Inhibitors of fibroblast growth factor receptor kinases External link
Filling date: 7 Sep 2025 Issue date: 31 May 2022
Application
Utility: INHIBITORS OF RAF KINASES External link
Filling date: 7 Sep 2025 Issue date: 14 Apr 2022
Application
Utility: INHIBITORS OF RAF KINASES External link
Filling date: 7 Sep 2025 Issue date: 30 Sep 2021
Grant
Utility: Inhibitors of RAF kinases External link
Filling date: 7 Sep 2025 Issue date: 24 Aug 2021
Application
Utility: INHIBITORS OF RAF KINASES External link
Filling date: 7 Sep 2025 Issue date: 12 Aug 2021
Application
Utility: INHIBITORS OF CYCLIN-DEPENDENT KINASES External link
Filling date: 7 Sep 2025 Issue date: 6 May 2021
Application
Utility: INHIBITORS OF CYCLIN-DEPENDENT KINASES External link
Filling date: 7 Sep 2025 Issue date: 25 Feb 2021
Grant
Utility: Inhibitors of RAF kinases External link
Filling date: 7 Sep 2025 Issue date: 23 Feb 2021
Grant
Utility: Inhibitors of cyclin-dependent kinases External link
Filling date: 7 Sep 2025 Issue date: 19 Jan 2021
Application
Utility: INHIBITORS OF RAF KINASES External link
Filling date: 7 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: INHIBITORS OF CYCLIN-DEPENDENT KINASES External link
Filling date: 7 Sep 2025 Issue date: 23 Jan 2020

Showing 1 to 15 of 15 patents.